You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Swiss MS Cohort (SMSC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing-Remitting Trial in Switzerland (serum Neurofilament Filament Light chain (sNfL) monitoring)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • serum Neurofilament Filament Light chain (sNfL) monitoring
  • Basel, Basel Stadt, Switzerland
  • +7 more
Oct 17, 2023

Multimodal Evoked Potentials for Predicting Disease Progression

Active, not recruiting
  • Multiple Sclerosis
  • multimodal evoked potentials (mmEP)
  • Basel, Switzerland
  • +2 more
Nov 2, 2021

Disease Modifying Therapies on COVID-19 Outcomes and Antibody

Recruiting
  • Multiple Sclerosis
  • COVID-19 (Severe Coronavirus Disease 2019)
  • data collection
  • analysis of blood samples
  • Aarau, Switzerland
  • +6 more
Apr 11, 2022

Multiple Sclerosis

Recruiting
  • Multiple Sclerosis
  • MS-adapted AWIS questionnaire (MS-AWIS)
  • infection diary (MS-AWIS diary)
  • Basel, Switzerland
    University Hospital Basel, Department of Neurology
Aug 3, 2021

Multiple Sclerosis (MS) Trial in Basel (SC MRI, patient questionnaire)

Not yet recruiting
  • Multiple Sclerosis (MS)
  • SC MRI
  • patient questionnaire
  • Basel, Switzerland
    University Hospital Basel, Department of Neurology
May 17, 2022

Spinal Cord Analysis in Multiple Sclerosis

Completed
  • Multiple Sclerosis
  • spinal cord MRI
  • Basel, Switzerland
    Dep. of Neurology, University Hospital Basel
Mar 30, 2020

Multiple Sclerosis Trial in Zurich

Recruiting
  • Multiple Sclerosis
    • Zurich, Switzerland
      University of Zurich; Epidemiology, Biostatistics & Prevention I
    May 3, 2022

    MSPT Device in Routine Clinical Practice in Swiss Healthcare

    Recruiting
    • Multiple Sclerosis
    • Clinically Isolated Syndrome
    • MSPT
    • Bern, Switzerland
      Inselspital Bern, Ambulantes Neurozentrum
    Nov 1, 2022

    Narcolepsy, Idiopathic Hypersomnia, Hypersomnolence Disorder Trial in Bern

    Recruiting
    • Narcolepsy
    • +2 more
      • Bern, Switzerland
        Claudio L Bassetti
      May 17, 2022

      Swiss Multiple Sclerosis Cohort-Study

      Recruiting
      • Multiple Sclerosis
        • Aarau, AG, Switzerland
        • +7 more
        Jan 30, 2020

        Swiss Chiropractic Cohort (Swiss ChiCo) Study: Patient Cohort

        Active, not recruiting
        • Musculoskeletal Pain
        • Usual chiropractic care
        • Zurich, Switzerland
          Balgrist University Hospital
        Oct 24, 2022

        Opioid Use, Unspecified Trial in Zurich (Fentanyl)

        Recruiting
        • Opioid Use, Unspecified
        • Zurich, Switzerland
          University's Children Hospital
        Feb 13, 2023

        SASL Swiss Cirrhosis Cohort

        Recruiting
        • Liver Cirrhosis
        • Data collection
        • Lugano, Ticino, Switzerland
        • +9 more
        Oct 17, 2023

        Kesimpta® in Swiss Multiple Sclerosis Patients -Observational

        Recruiting
        • Multiple Sclerosis
        • Ofatumumab
        • Baden, Aargau, Switzerland
        • +17 more
        Jan 20, 2023

        Mayzent on SPMS Patients in a Long-term Non-interventional Study

        Recruiting
        • Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity
        • Siponimod
        • Baden, Aargau, Switzerland
        • +8 more
        May 16, 2022

        (Swiss ChiCo) Study: A Nationwide Practice-Based Research

        Completed
        • Musculoskeletal Pain
          • Zurich, Switzerland
            Balgrist University Hospital
          Jun 21, 2022

          Kesimpta Pregnancy and Infant Safety Study Using Real World Data

          Not yet recruiting
          • Multiple Sclerosis
          • Multiple sclerosis disease modifying drug
          • (no location specified)
          Nov 27, 2023

          Obesity and Pediatric Multiple Sclerosis

          Recruiting
          • Multiple Sclerosis
            • Philadelphia, Pennsylvania
            • +1 more
            Oct 31, 2022

            Multiple Sclerosis: FutureMS-2 -Observational Cohort and

            Enrolling by invitation
            • Multiple Sclerosis
              • Aberdeen, United Kingdom
              • +4 more
              Aug 18, 2023

              Ozanimod Exposure During Pregnancy in Multiple Sclerosis and

              Active, not recruiting
              • Multiple Sclerosis
              • Eden Prairie, Minnesota
                OptumInsight Life Sciences Inc
              Nov 9, 2023

              Bleeding of Unknown Cause: a Swiss Case-control Study

              Not yet recruiting
              • Bleeding Disorder
              • Thrombin generation
              • +3 more
              • Geneva, Switzerland
                University Hospital
              Feb 6, 2023

              Immunocompromised Patients Trial in Switzerland (Moderna COVID-19 Vaccine, mRNA-1273 (100 µg), Pfizer-BioNTech COVID-19 Vaccine

              Active, not recruiting
              • Immunocompromised Patients
              • Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)
              • Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)
              • Basel, Switzerland
              • +3 more
              Oct 18, 2022

              Multiple Sclerosis Trial (Natalizumab)

              Not yet recruiting
              • Multiple Sclerosis
              • (no location specified)
              Jun 21, 2023

              Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and

              Not yet recruiting
              • Multiple Sclerosis
              • Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic plasmacytoid Dendritic Cells
              • (no location specified)
              Oct 10, 2022

              Diabetes Trial in Seattle (Diabetes Prevention Program)

              Active, not recruiting
              • Diabetes
              • Diabetes Prevention Program
              • Seattle, Washington
                IREACH
              Jun 4, 2022